A pioneer in functional precision medicine shaping the future of cancer care.

By turning complex tumor biological response into actionable insight, we transform cancer treatment at scale. Our technology delivers rapid, personalized treatment intelligence directly from patient-derived biopsies, with applications spanning drug development to clinical decision-making.

From biopsy to decision. In under a week.

Built on breakthrough science from Ecole Polytechnique and Institut Pasteur, our platform combines miniaturized tumor-on-chip technology and AI imaging to uncover personalized drug response patterns. At a time when 50% of first-line treatments fail, we enable clinicians and drug developers to find the most effective therapy for every patient.

Only 50 cells needed

Scalable

Rapid

End-to-end

Patient-centric

Cancer agnostic

Modernizing the approach to drug discovery

Something

Improving the predictability of preclinical studies

Something

Enabling diverse impactful use-cases

CRISPR, T-Cell Potency, Drug screening

Our Product

We are the next-gen personnalized medicine

Our technology allows to automatically test up to 800 different conditions on 1000 microtumors at a time, and makes personnalized treatments way easier.